Schizophrenia A-level Revisions Notes

Biological explanations

Biological explanations for schizophrenia: genetics and neural correlates, including the
dopamine hypothesis.

The biological approach asserts that schizophrenia is a physical illness resulting from organic malfunctions.

This perspective focuses on three primary areas: the inheritance of specific gene clusters, the dysregulation of the neurotransmitter dopamine, and structural abnormalities within the brain’s physical architecture.

---

Genetic Explanations: Heritability and Polygenicity

Genetic theories propose that schizophrenia is a heritable condition.

Since no single gene is responsible, researchers categorize it as polygenic (caused by many genes) and aetiologically heterogenous (different genetic combinations can produce the same symptoms in different people).

Concordance Rates and Family Studies

To separate nature from nurture, psychologists use concordance rates—the probability that two people will both have the disorder.

• Twin Studies: Gottesman (1991) identified a 48% concordance rate for monozygotic (MZ) twins, who share 100% of their DNA. In contrast, dizygotic (DZ) twins showed only a 17% concordance.
• Adoption Studies: Kety and Ingraham (1992) found that the risk of schizophrenia was ten times higher among biological relatives than adoptive relatives. This suggests that the genetic link remains potent even when the individual is raised in a different environment.

Genome-Wide Association Studies (GWAS)

Modern molecular biology has identified specific locations on the human genome associated with the disorder.

Ripke et al. (2014)

• Aim: To identify specific genetic variations that increase the risk of schizophrenia.
• Procedure: Researchers compared the entire genetic makeup of 37,000 patients with 113,000 healthy controls.
• Findings: They identified 108 separate genetic loci (locations) associated with the disorder.
• Conclusions: Many of these genes are responsible for the functioning of dopamine receptors and the immune system, providing a physical map for schizophrenia’s development.

---

Dopamine Hypothesis

Dopamine is a neurotransmitter that facilitates communication between neurons in the brain.

The dopamine hypothesis argues that an imbalance in this chemical messenger drives the symptoms of schizophrenia.

Hyperdopaminergia (Excess)

The original hypothesis focused on high dopamine activity in the subcortex and the mesolimbic pathway.

An excess of dopamine—either through over-active neurons or an overabundance of D2 receptors—is believed to cause positive symptoms like auditory hallucinations.

Hypodopaminergia (Deficit)

A more recent revision focuses on low levels of dopamine in the pre-frontal cortex (the mesocortical pathway).

This deficit is linked to negative symptoms, such as avolition and cognitive impairment.

Empirical Validation: Dopamine

Curren et al. (2004)

• Aim: To observe the effects of dopamine agonists on schizophrenic symptoms.
• Procedure: Researchers administered amphetamines, which increase dopamine levels, to both healthy and schizophrenic participants.
• Findings: Amphetamines induced psychotic symptoms in healthy individuals and significantly exacerbated existing symptoms in patients.
• Conclusions: Elevated dopamine levels are a direct physiological trigger for schizophrenic episodes.

---

Neural Correlates: Structural Brain Abnormalities

The neural correlates explanation suggests that specific brain structures function or appear differently in schizophrenic patients.

Ventricular Enlargement

Ventricles are fluid-filled cavities in the brain.

Research has consistently shown that schizophrenic patients often have significantly larger ventricles than healthy controls.

This enlargement suggests that the surrounding brain tissue has shrunk or failed to develop, particularly in the pre-frontal cortex.

Regional Activation and Symptoms

Neuroimaging allows researchers to link specific brain regions to specific symptoms:

• Auditory Hallucinations: Allen et al. (2007) found lower activation levels in the superior temporal gyrus and anterior cingulate gyrus during hallucinatory episodes.
• Speech Poverty: Reduced activity in Wernicke’s area (the region responsible for speech comprehension) is negatively correlated with the severity of thought disorders.

---

Critical Evaluation of Biological Models

The Issue of Causation

A major weakness in biological research is the “direction of causality” problem.

While brain scans show enlarged ventricles, it is unclear if these structural changes caused the schizophrenia or if the long-term suffering and stress of the disorder (or the medication used to treat it) caused the brain damage.

Biological Reductionism

Critics argue that these theories are too simplistic.

By focusing only on dopamine, researchers may overlook the role of other neurotransmitters like glutamate and serotonin.

Furthermore, biological models often ignore the “stress” component of the diathesis-stress model, failing to explain why some people with high genetic risk never develop the disorder.

Environmental Influence

The fact that MZ twins only have a 48% concordance rate—rather than 100%—proves that biology is not destiny.

Environmental factors, such as dysfunctional family dynamics or urban living, must interact with biological vulnerabilities to trigger the onset of the illness.

Psychological Explanations

Psychological explanations for schizophrenia: family dysfunction and cognitive explanations,
including dysfunctional thought processing.

Psychological theories of schizophrenia emphasize that environmental stressors and cognitive deficits drive the disorder’s development.

Researchers focus on how specific social interactions and internal processing errors create and sustain psychotic symptoms.

Family Dysfunction as a Social Stressor

Family dysfunction refers to maladaptive patterns of communication and high levels of interpersonal conflict within the domestic environment.

These stressors often serve as the primary environmental triggers for individuals with an underlying genetic vulnerability.

The Schizophrenogenic Mother

Fromm-Reichmann (1948) identified the “schizophrenogenic mother” as a primary cause of paranoid delusions.

This term describes a parent who is simultaneously cold, rejecting, and overly controlling of her child’s behavior.

Such parenting creates a climate of secrecy and tension, leading to profound distrust in the developing child.

This lack of emotional security eventually manifests as a break from reality.

Double Bind Theory

Bateson et al. (1956) proposed the Double Bind Theory to explain disorganized thinking.

A double bind is a communication paradox where a person receives two or more conflicting messages. For example, a parent may verbally express love while pulling away with cold body language.

The child cannot resolve the contradiction and fears punishment regardless of their response.

Study: Bateson et al. (1956)

• Aim: To investigate how contradictory communication patterns within families contribute to the development of schizophrenia symptoms.
• Procedure: Clinical observations and interviews were conducted with patients and their families to identify recurring communication styles.
• Findings: Researchers observed that patients were frequently placed in “no-win” situations where verbal and non-verbal cues conflicted.
• Conclusions: Chronic exposure to these binds prevents children from forming a coherent reality, leading to hallucinations and disorganized speech.

High Expressed Emotion (EE)

Expressed Emotion (EE) measures the quality of the emotional environment directed toward a patient by their caregivers.

It consists of three main elements: verbal criticism, hostility, and emotional over-involvement.

High EE environments serve as a powerful psychological stressor that frequently triggers symptomatic relapse.

Study: Vaughn and Leff (1976)

• Aim: To assess the influence of the home environment on the relapse rates of recently discharged schizophrenia patients.
• Procedure: Patients were monitored following their return to either high-EE or low-EE households after hospital treatment.
• Findings: Patients returning to high-EE homes showed a 51% relapse rate, whereas low-EE homes showed only 13%.
• Conclusions: The emotional atmosphere of the family is a decisive factor in maintaining or worsening the disorder’s course.

Theoretical Limitations

Despite practical successes, the family dysfunction model faces significant scrutiny regarding its scientific validity and ethical impact.

Critics argue that the theory often confuses the consequences of the illness with its causes.

The Direction of Causality

Establishing a clear cause-and-effect relationship remains the primary challenge for this theory.

Most research is correlational, meaning researchers cannot confirm if family conflict triggers schizophrenia or if the stress of managing a symptomatic child disrupts the family.

Study: Mischler and Waxler (1968)

• Aim: To observe how mothers adapt their communication styles when interacting with children of differing mental health statuses.
• Procedure: Controlled observations were conducted of mothers speaking to their daughters with schizophrenia versus their neurotypical daughters.
• Findings: Mothers utilized significantly different communication patterns when addressing their ill children.
• Conclusions: Dysfunctional communication is likely a reaction to the child’s symptoms rather than the original cause of the disorder.

Methodological Validity and Retrospective Data

Much evidence relies on retrospective data, which refers to memories of past events reported by patients during adulthood. This method is notoriously unreliable in clinical populations.

Positive symptoms like delusions can distort a patient’s perception of their upbringing.

Furthermore, early researchers lacked objectivity, often seeking “crazy-making” traits in parents to confirm their existing biases.

Social Sensitivity and Ethical Guilt

The family dysfunction explanation is highly socially sensitive because it identifies parents as the source of their child’s suffering.

Terms like “schizophrenogenic mother” impose a heavy burden of guilt on families already struggling with a crisis.

This psychological pressure can increase domestic tension, inadvertently triggering the very relapses the theory seeks to explain.

The Interactionist Perspective

Focusing solely on the family is considered a form of environmental reductionism, as it ignores biological foundations.

Schizophrenia is now largely understood through the Diathesis-Stress Model.

This interactionist approach posits that a biological vulnerability (diathesis) must be present, which is then activated by a social stressor (stress).

Without the genetic predisposition, even the most dysfunctional family environment is unlikely to produce the disorder.

---

Cognitive Explanations of Schizophrenia

The cognitive approach suggests that schizophrenia results from dysfunctional thought processing and impaired mental mechanisms.

It focuses on how the brain filters information and interprets internal versus external stimuli.

Attentional Bias

Bentall (1994) argued that sufferers possess an attentional bias, which is a tendency to focus excessively on threatening stimuli.

This hyper-vigilance causes individuals to misinterpret mundane events as personal threats or persecutory plots.

A person might focus on a stranger’s hand in their pocket and conclude they are concealing a weapon.

Dysfunctional Thought Processing

Christopher Frith (1992) identified two specific cognitive systems that fail in those with schizophrenia.

These failures directly correlate to the positive and disorganized symptoms observed in clinical settings.

• Metarepresentation: This is the cognitive ability to reflect on our own thoughts and identify them as internal. Dysfunction here leads to “thought insertion,” where patients believe their own thoughts are being placed there by others.
• Central Control: This refers to the ability to suppress automatic responses and perform deliberate actions. If central control fails, the individual cannot stop tangential thoughts from intruding into speech, resulting in word salad or derailment.

Study: Stirling et al. (2006)

• Aim: To test the theory of central control dysfunction in schizophrenia patients using the Stroop Test.
• Procedure: Thirty patients and 18 controls were required to name ink colors while ignoring the written color names.
• Findings: The schizophrenia group took significantly longer (over double the time) to name the colors compared to the controls.
• Conclusions: Patients struggle to suppress automatic impulses, confirming a deficit in the cognitive mechanism of central control.

Theoretical Limitations

A major limitation of cognitive theories involves the “direction of causality” problem.

While these models effectively explain proximal causes—the immediate cognitive failures that produce symptoms—they often overlook distal causes.

Proximal vs. Distal Etiology

Proximal causes refer to the current cognitive deficits, such as impaired metarepresentation, that explain why a patient hears voices.

In contrast, distal causes refer to the initial origins of the condition, such as genetic inheritance or neurochemical imbalances.

Integration with Biological Factors

It is highly probable that structural brain abnormalities or dopamine dysregulation represent the true root causes of the disorder.

These biological factors likely create the faulty cognitions observed by psychologists.

Consequently, cognitive explanations are often viewed as incomplete because they describe the symptoms’ mechanisms rather than the disorder’s primary source.

---

Drug Therapy

Drug therapy: typical and atypical antipsychotics.

Typical Antipsychotics

Typical antipsychotics, or first-generation antipsychotics, have served as the primary pharmacological intervention for schizophrenia since the mid-20th century.

These conventional medications, such as Chlorpromazine and Haloperidol, are administered via tablets, syrups, or intramuscular injections to manage acute psychotic episodes.

Mechanism of Action: The Dopamine Hypothesis

Typical antipsychotics function as dopamine antagonists, which are chemicals that reduce the activity of a neurotransmitter by blocking its receptors.

These drugs target D2 receptors in the mesolimbic pathway, a brain region associated with reward and sensory perception.

By binding to roughly 60% to 70% of these receptors, the medication prevents dopamine from stimulating the postsynaptic neuron.

This blockade effectively arrests overactive dopaminergic signaling, which researchers believe is the primary cause of positive symptoms like hallucinations.

Beyond their primary neurological target, many typical antipsychotics influence histamine receptors.

This secondary interaction produces a powerful sedative effect, leading to the drug’s frequent use as a tool for calming highly anxious or aggressive patients in clinical settings.

---

Empirical Support and Economic Utility

The widespread adoption of drug therapy is supported by extensive meta-analytic data and practical financial advantages.

These treatments allow for a level of patient independence that was historically impossible before the 1950s.

Study: Thornley et al. (2003)

• Aim: To compare the clinical effectiveness of Chlorpromazine against a placebo in the treatment of schizophrenia.
• Procedure: A systematic review was conducted on 13 randomized trials involving 1,121 participants.
• Findings: Chlorpromazine was associated with significantly reduced symptom severity and lower relapse rates than the placebo.
• Conclusions: Typical antipsychotics are an effective tool for stabilizing patients and improving their overall level of functioning.

Study: Leucht et al. (2012)

• Aim: To evaluate the necessity of maintenance medication for preventing the return of symptoms.
• Procedure: A meta-analysis of 65 studies was performed on patients who were either maintained on antipsychotics or switched to a placebo.
• Findings: Within one year, 64% of the placebo group relapsed compared to only 27% of those staying on their medication.
• Conclusions: Continuous drug therapy is superior to placebo at maintaining long-term psychological stability.

Typical antipsychotics are also highly cost-effective compared to specialized psychological interventions like Cognitive Behavioral Therapy (CBT).

Because they require minimal patient effort, they are often more accessible for individuals suffering from severe cognitive impairment or a lack of motivation.

---

Physiological Risks and Ethical Constraints

While effective at symptom reduction, typical antipsychotics are non-selective, meaning they block dopamine throughout the entire brain.

This lack of precision leads to significant neurological side effects and raises concerns about patient autonomy.

Limited Scope

Typical antipsychotics only treat the positive symptoms of schizophrenia and are largely ineffective at addressing negative symptoms, such as avolition or speech poverty

Extrapyramidal Side Effects

The most common complications are extrapyramidal symptoms, which are physical movement disorders resulting from dopamine blockade in the motor pathways.

Mild issues include lethargy or dry mouth, but chronic use can lead to tardive dyskinesia.

This condition involves involuntary facial movements, such as grimacing or rapid eye blinking, and is often irreversible even after medication ceases.

Neuroleptic Malignant Syndrome (NMS)

A rare but potentially fatal risk is Neuroleptic Malignant Syndrome (NMS).

This occurs when dopamine blockage affects the hypothalamus, leading to high fever, muscle rigidity, and autonomic instability.

These severe physiological costs frequently result in high dropout rates, where patients stop taking their medication and suffer a “revolving door” of hospital readmissions.

High Dropout Rates

While the drugs are effective, the severity of the side effects means that the costs can sometimes outweigh the benefits.

The unpleasant side effects lead many patients to abandon their medication, resulting in a “revolving door” effect where they inevitably suffer a severe relapse of symptoms

The “Chemical Straightjacket” Debate

Ethical concerns persist regarding the use of these drugs for sedation rather than therapy.

Critics like Healy (2012) argue that drug efficacy data may be misleading.

Instead of curing the underlying pathology, the drugs may simply sedate patients into a state of compliance.

This has led to the term “chemical straightjacket,” describing the use of medication to make patients easier for hospital staff to manage rather than improving the patient’s internal experience.

---

Atypical Antipsychotics

Atypical antipsychotics, or second-generation antipsychotics, represent a pharmacological advancement designed to treat schizophrenia with greater precision.

Developed in the 1970s, these medications aim to suppress a wider range of symptoms while reducing the motor-function side effects associated with earlier drugs.

Multifaceted Mechanism of Action

Atypical antipsychotics operate through a broader neurochemical profile than their predecessors.

While they still function as dopamine antagonists, they also modulate serotonin and glutamate activity to balance brain chemistry.

Clozapine

Clozapine is a potent antagonist for dopamine and serotonin receptors, while also acting as an agonist for glutamate.

An agonist is a substance that initiates a physiological response when combined with a receptor.

This unique interaction helps alleviate “negative symptoms,” such as avolition (a total lack of motivation) and speech poverty.

Because of its impact on serotonin, Clozapine is frequently used to treat comorbid depression, which affects approximately 50% of schizophrenia patients.

Risperidone

Risperidone was developed to provide a safer alternative to Clozapine by targeting dopamine and serotonin receptors with higher affinity.

Affinity refers to the strength with which a drug binds to its target receptor.

Because it binds so strongly to D2 receptors, Risperidone is effective in significantly smaller doses.

This lower dosage typically results in a milder side-effect profile for many patients.

---

Empirical Validation and Economic Benefits

Atypical medications are often the preferred clinical choice due to their superior performance in treatment-resistant cases and their lower dropout rates among patients.

Study: Bagnall (2003)

• Aim: To compare the clinical efficacy and tolerability of atypical antipsychotics against typical, first-generation drugs.
• Procedure: A systematic review was conducted on 232 studies involving various drug trials.
• Findings: Atypical antipsychotics were more effective at treating overall symptoms and showed lower attrition rates (patients leaving the study early).
• Conclusions: Second-generation drugs offer a more sustainable treatment path due to increased effectiveness and better patient compliance.

Study: Meltzer (2012)

• Aim: To evaluate the effectiveness of Clozapine for patients who did not respond to standard antipsychotic treatments.
• Procedure: Clinical outcomes were analyzed for “treatment-resistant” patients who had failed to improve on typical medications.
• Findings: Clozapine was effective in 30% to 50% of cases that were previously considered untreatable.
• Conclusions: Clozapine provides a critical secondary line of defense for the most severe and persistent cases of schizophrenia.

Beyond clinical metrics, these drugs provide substantial economic utility.

By stabilizing both positive and negative symptoms, they facilitate a patient’s return to the workforce.

This reduces the financial burden on public health systems by preventing expensive, long-term institutionalization.

---

Physiological Risks and Clinical Management

Despite their advantages, atypical antipsychotics are not without significant medical risks.

Clinicians must perform a rigorous cost-benefit analysis before prescribing these potent chemical agents.

Metabolic Side Effects

While atypical drugs reduce the risk of movement disorders, they increase the likelihood of metabolic complications.

Patients frequently experience significant weight gain, which can lead to secondary conditions like Type 2 diabetes and cardiovascular disease.

These physical health risks can diminish a patient’s quality of life and discourage continued adherence to the medication.

Agranulocytosis

Clozapine carries a specific and life-threatening risk known as agranulocytosis.

Agranulocytosis is a severe form of leukopenia, a condition where the white blood cell count drops to dangerously low levels.

This leaves the patient highly vulnerable to infection.

Consequently, any patient prescribed Clozapine must undergo mandatory and regular blood monitoring to ensure their safety.

Relapse and Quality of Life

The presence of side effects can severely reduce a patient’s quality of life.

This can lead to patients stopping their treatment entirely, which then results in them experiencing a relapse of their schizophrenic symptoms.

Because of these risks, clinicians must carry out a cost-benefit analysis to determine whether the benefits of symptom reduction outweigh the potential costs of the side effects for each individual patient.

Positive Economic Implications

By successfully reducing the severity of a patient’s symptoms, atypical antipsychotics can have significant economic benefits.

Effective drug therapy enables individuals to potentially return to work and prevents the need for them to be frequently readmitted to hospitals or receive full-time institutional care, thereby reducing the negative financial impact on the economy and public health services